Clinical Trial Update: Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating acetazolamide for respiratory failure in the context of metabolic alkalosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Alkalosis
• Respiratory Failure

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Respiratory Insufficiency, Alkalosis | Phase 4 | Status: COMPLETED